Research location

Wilrijk

Belgium

Published trials178

Site observations178

Linked trials published178

Page4 / 4

Research activity in Wilrijk

Belgium

CureCurrent currently publishes aggregate city-level research activity for this location: 178 trials and 178 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Wilrijk

178 linked trials · page 4 of 4

SU11248 as Consolidation After Response to Taxanes in Metastatic Breast CancerNCT00270413 · 2006-01-01 · 1 site observation

Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast CancerNCT00248170 · 2005-12-01 · 1 site observation

Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal WomenNCT00107016 · 2005-03-01 · 1 site observation

A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast CancerNCT00649090 · 2005-03-01 · 1 site observation

Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone TherapyNCT00172055 · 2004-12-01 · 1 site observation

SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent AsthmaNCT00290264 · 2004-12-01 · 1 site observation

An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)NCT00949910 · 2004-11-01 · 1 site observation

Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.NCT00174304 · 2004-10-01 · 1 site observation

Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe HypertensionNCT00095394 · 2004-09-01 · 1 site observation

Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate CancerNCT01081873 · 2004-06-01 · 1 site observation

An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of GalantamineNCT00297414 · 2004-06-01 · 1 site observation

The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast CancerNCT00171314 · 2004-03-01 · 1 site observation

Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerNCT00082433 · 2003-11-01 · 1 site observation

Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa StudyNCT00229697 · 2003-10-01 · 1 site observation

Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane TherapyNCT00067314 · 2003-06-01 · 1 site observation

Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast CancerNCT00062400 · 2003-05-01 · 1 site observation

Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast CancerNCT00066378 · 2003-05-01 · 1 site observation

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.NCT00171340 · 2003-05-01 · 1 site observation

This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.NCT00059722 · 2003-05-01 · 1 site observation

"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased RiskNCT00056407 · 2003-03-01 · 1 site observation

Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast CancerNCT00049660 · 2002-09-01 · 1 site observation

Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On TamoxifenNCT00038103 · 2002-01-01 · 1 site observation

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast CancerNCT00017095 · 2001-03-01 · 1 site observation

Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung CancerNCT00006229 · 2000-04-04 · 1 site observation

Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast CancerNCT00038467 · 1998-02-01 · 1 site observation

Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically RemovedNCT00002851 · 1996-07-01 · 1 site observation

Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast CancerNCT00002777 · 1996-05-01 · 1 site observation

Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast CancerNCT00097383 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.